Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Apr 2, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Incyte Corp
| 413 |
$56.97 | $23,528.61 | +3.25% | 13.12K |
Mar 28
| |||||||
Incyte Corp
| 423 |
$62.79 | $26,560.17 | +3.44% | 12.7K |
Dec 29
| |||||||
Incyte Corp
| 389 |
$57.77 | $22,472.53 | +3.27% | 12.28K |
Sep 29
| |||||||
Incyte Corp
| 390 |
$62.25 | $24,277.50 | +3.39% | 11.89K |
Jun 30
| |||||||
Incyte Corp
| 2.5K |
—
|
—
| +27.85% | 11.5K |
Jun 14
| |||||||
Acadia Pharmaceuticals Inc
| 18K |
—
|
—
| +1,800.20% | 19K |
Jun 22 - Jun 1
| |||||||
Phasebio Pharmaceuticals Inc
| 3.75K |
—
|
—
| +62.50% | 9.75K |
May 19
| |||||||
Incyte Corp
| 326 |
$72.27 | $23,560.02 | +3.76% | 8.99K |
Mar 31
| |||||||
Incyte Corp
| 302 |
$80.32 | $24,256.64 | +3.61% | 8.67K |
Dec 30
|
Scheduled
| ||||||
Incyte Corp
| 165 |
$69.59 | $11,482.35 | +2.01% | 8.37K |
Oct 19
|
Scheduled
| ||||||
Incyte Corp
| 250 |
$66.64 | $16,660.00 | +3.14% | 8.2K |
Sep 30
|
Scheduled
| ||||||
Incyte Corp
| 236 |
$75.97 | $17,928.92 | +3.06% | 7.95K |
Jun 30
|
Scheduled
| ||||||
Incyte Corp
| 2.14K |
—
|
—
| +38.48% | 7.72K |
Jun 15
| |||||||
Acadia Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 7
| |||||||
Phasebio Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
May 19
| |||||||
Incyte Corp
| 240 |
$79.42 | $19,060.80 | +4.50% | 5.57K |
Mar 31
|
Scheduled
| ||||||
Incyte Corp
| 253 |
$73.40 | $18,570.20 | +4.98% | 5.33K |
Dec 31
|
Scheduled
| ||||||
Incyte Corp
| 237 |
$68.78 | $16,300.86 | +4.89% | 5.08K |
Sep 30
|
Scheduled
| ||||||
Incyte Corp
| 208 |
$84.13 | $17,499.04 | +4.49% | 4.84K |
Jun 30
|
Scheduled
| ||||||
Acadia Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 22
| |||||||
Phasebio Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 3
| |||||||
Incyte Corp
| 1.92K |
—
|
—
| +70.93% | 4.63K |
May 26
| |||||||
Incyte Corp
| 219 |
$81.27 | $17,798.13 | +8.79% | 2.71K |
Mar 31
|
Scheduled
| ||||||
Incyte Corp
| 207 |
$86.98 | $18,004.86 | +9.06% | 2.49K |
Dec 31
|
Scheduled
| ||||||
Phasebio Pharmaceuticals Inc
| 6K |
$4.12 | $24,720.00 |
∞
| 6K |
Dec 3
| |||||||
Incyte Corp
| 187 |
$89.74 | $16,781.38 | +8.91% | 2.29K |
Sep 30
|
Scheduled
| ||||||
Karuna Therapeutics, Inc.
| -10.00K |
$83.32 | -$833,200.00 | -15.35% | 55.16K |
Aug 12
|
Scheduled
| ||||||
Karuna Therapeutics, Inc.
| -10.00K |
$93.40 | -$934,000.00 | -13.30% | 65.16K |
Jul 13
|
Scheduled
| ||||||
Incyte Corp
| 152 |
$103.97 | $15,803.44 | +7.81% | 2.1K |
Jun 30
|
Scheduled
| ||||||
Acadia Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 23
| |||||||
Karuna Therapeutics, Inc.
| -30.00K |
$91.79 | -$2,753,700.00 | -28.53% | 75.16K |
Jun 12
|
Scheduled
| ||||||
Karuna Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 4
| |||||||
Phasebio Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 3
| |||||||
Incyte Corp
| 1.28K |
—
|
—
| +193.07% | 1.95K |
May 26
| |||||||
Incyte Corp
| 202 |
$73.23 | $14,792.46 | +43.72% | 664 |
Mar 31
|
Scheduled
| ||||||
Karuna Therapeutics, Inc.
| 105.16K |
—
|
—
|
∞
| 105.16K |
Mar 9
| |||||||
Incyte Corp
| 462 |
—
|
—
|
∞
| 462 |
Dec 17
| |||||||
Incyte Corp
|
0
|
—
|
—
|
—
|
0
| ||||||||
Karuna Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 27
| |||||||
Acadia Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 26
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.